The AI-Powered Future of K-Beauty: APR Bets Big on Smart Hardware and Custom Routines
K-beauty’s growth engine is rapidly expanding from traditional cosmetics into at-home beauty devices. As consumer demand for clinical-grade...
Search results for "biotech"
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral targeted anticancer candidate...
Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US
Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4...
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
GC Pharma Partners with France’s Osivax to Develop Next-Generation Combination Flu Vaccine
GC Pharma has entered into a strategic partnership with French biotech firm Osivax to develop and commercialize a...
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
From Liposuction Waste to Skin Models: Discarded Human Fat Repurposed for Medical Research
Human fat once discarded as medical waste after liposuction is set to take on new life as a crucial material for...
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation
Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million...